Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?

Publikation

Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?

Wissenschaftlicher Artikel/Review - 01.05.2006

Dummer Reinhard, Cozzio Antonio, Urosevic Mirjana

Zitation

Dummer R, Cozzio A, Urosevic M. Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?. Exp Dermatol 2006; 15:392-400.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Exp Dermatol 2006; 15

Veröffentlichungsdatum

01.05.2006

ISSN (Druck)

0906-6705

Seiten

392-400

Kurzbeschreibung/Zielsetzung

The cutaneous environment hosts a number of hematopoietic neoplasms that are dominated by primary cutaneous (PC) T-cell lymphomas. Recent progress in molecular biology and immunology has provided tools to investigate the pathogenesis and the biology of these neoplasms. This review highlights newest findings concerning the immune biology of CD4+ CD56+ hematodermic neoplasms, and PC T-cell and B-cell lymphomas, speculating how these can be translated into more sophisticated, biology-based treatment approaches in the near future.